Connor, Clark & Lunn Investment Management Ltd. Mei Pharma, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$22 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.41 - $8.8 $46,654 - $1 Million	113,791 Added 148.72%	190,305 $74,000
Q2 2022 Aug 05, 2022	BUY	$0.42 - $0.65 $32,135 - $49,734	76,514 New	76,514 $46,000
Q1 2022 May 12, 2022	SELL	$0.54 - $2.74 $64,623 - $327,906	-119,674 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$2.33 - $3.37 $229,952 - $332,592	-98,692 Reduced 45.2%	119,674 $320,000
Q3 2021 Nov 12, 2021	SELL	$2.52 - $2.99 $223,377 - $265,039	-88,642 Reduced 28.87%	218,366 $603,000
Q2 2021 Aug 12, 2021	SELL	$2.6 - $3.65 $169,561 - $238,038	-65,216 Reduced 17.52%	307,008 $875,000
Q1 2021 May 13, 2021	SELL	$2.73 - $4.5 $209,751 - $345,744	-76,832 Reduced 17.11%	372,224 $1.28 Million
Q4 2020 Feb 16, 2021	BUY	$2.6 - $3.32 $2,238 - $2,858	861 Added 0.19%	449,056 $1.19 Million
Q3 2020 Nov 12, 2020	BUY	$2.46 - $4.27 $70,129 - $121,729	28,508 Added 6.79%	448,195 $1.4 Million
Q2 2020 Aug 13, 2020	BUY	$1.45 - $4.3 $238,529 - $707,362	164,503 Added 64.46%	419,687 $1.73 Million
Q1 2020 May 13, 2020	BUY	$0.75 - $2.55 $8,205 - $27,896	10,940 Added 4.48%	255,184 $410,000
Q4 2019 Feb 12, 2020	SELL	$1.65 - $2.48 $12,045 - $18,104	-7,300 Reduced 2.9%	244,244 $606,000
Q3 2019 Nov 13, 2019	SELL	$1.48 - $2.52 $27,665 - $47,106	-18,693 Reduced 6.92%	251,544 $423,000
Q2 2019 Aug 07, 2019	SELL	$2.45 - $3.32 $43,308 - $58,687	-17,677 Reduced 6.14%	270,237 $676,000
Q1 2019 May 08, 2019	SELL	$2.52 - $3.24 $43,407 - $55,809	-17,225 Reduced 5.64%	287,914 $884,000
Q4 2018 Feb 12, 2019	SELL	$1.92 - $4.1 $96,912 - $206,947	-50,475 Reduced 14.19%	305,139 $806,000
Q3 2018 Nov 13, 2018	BUY	$3.39 - $4.61 $13,861 - $18,850	4,089 Added 1.16%	355,614 $1.53 Million
Q2 2018 Aug 02, 2018	SELL	$1.89 - $4.95 $31,232 - $81,798	-16,525 Reduced 4.49%	351,525 $1.39 Million
Q1 2018 May 14, 2018	SELL	$2.06 - $2.38 $21,012 - $24,276	-10,200 Reduced 2.7%	368,050 $762,000
Q4 2017 Feb 09, 2018	SELL	$1.91 - $2.83 $61,311 - $90,843	-32,100 Reduced 7.82%	378,250 $794,000
Q3 2017 Nov 14, 2017	SELL	$2.44 - $2.91 $11,956 - $14,259	-4,900 Reduced 1.18%	410,350 $1.1 Million
Q2 2017 Aug 14, 2017	BUY	N/A	415,250	415,250 $992,000

Others Institutions Holding MEIP

# of Institutions

Shares Held

Call Options Held

Put Options Held

Urban Wealth Management, LLC

2K
Shares

$5,557
0.0% of portfolio

View Full List

About MEI Pharma, Inc.

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $370M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

More about MEIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account